Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.5600
+0.0020
+(0.13%)
As of 12:30:57 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-218,618
-218,618
-167,743
-127,379
-95,556
Investing Cash Flow
-106,004
-106,004
-180,322
62,067
71,947
Financing Cash Flow
334,372
334,372
362,021
87,264
48,556
End Cash Position
80,876
80,876
71,138
57,209
35,235
Capital Expenditure
-680
-680
-830
-431
-207
Issuance of Capital Stock
140,729
140,729
213,337
69,916
20,385
Issuance of Debt
121,120
121,120
29,700
--
24,895
Repayment of Debt
-86,554
-86,554
--
--
--
Free Cash Flow
-219,298
-219,298
-168,573
-127,810
-95,763
12/31/2021 - 2/25/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HQ1.MU Oruka Therapeutics Inc. R
9.60
0.00%
5KW.F SkinBioTherapeutics plc
0.2160
-2.70%
RPD.F Royalty Pharma plc
30.96
+0.55%
5CV.MU CureVac NV
2.8900
+0.35%
AM6.F Amicus Therapeutics, Inc.
8.40
-1.18%
ICY.SG Incyte Corp
64.00
-0.47%
600161.SS TIANTAN BIO
19.88
+0.05%
1S9.SG Seres Therapeutics Inc
0.6902
+1.77%
ISI.F Ionis Pharmaceuticals, Inc.
31.00
-0.06%
2H51.DU Ocugen Inc
0.5390
+3.95%